Buy Imatinib Online (IMATIB)

Generic GLEEVEC – prices, cost, how to order, india brands


Active substance: Imatinib
U.S. Brand: Gleevec
Indian Brand: IMATIB
Mfd by:
Strength: 100mg / 400mg
Form release: blister with 10 tablets
Shipping time: 7 – 21 days
Best price: 0.95 USD
Order: through request form


DescriptionDosages / How to take?Common Side EffectsLatest New'sPhoto's

Generic Imatinib under brand name Imatib sold in India company Cipla, many years and shows very good results to treat a cancer.

For best prices you need to order more than 300 pills, we offer better best prices if you will order via Bitcoin, we offer additional 20% discount. Shipping can be via EMS or RMS, also we can ship Imatinib from SIngapore to Europe or Canada. Sometimes we can ask a prescription.

It is the first member of a new class of agents that act by inhibiting particular tyrosine kinase enzymes, instead of non-specifically inhibiting rapidly dividing cells. Imatinib is an antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome.

tablet
  • 100mg
  • 400mg

how to take – more info

  • Most people do not experience all of the side effects listed.
  • Side effects are often predictable in terms of their onset and duration.
  • Side effects are almost always reversible and will go away after treatment is complete.
  • There are many options to help minimize or prevent side effects.
  • There is no relationship between the presence or severity of side effects and the effectiveness of the medication.
  • The side effects of Gleevec and their severity depend on how much of the drug is given.  In other words, high doses may produce more severe side effects.

more information…

Global Imatinib Mesylate Market

The Global Imatinib Mesylate Market is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The researchers offer a thorough description of the value chain and its distributor analysis. This Market analysis gives in-depth data which enhances the understanding, scope, and application of this report.

more info

Cost Effectiveness of Therapeutic Drug

Imatinib mesylate (IM) is a first-line treatment option for patients with chronic myeloid leukemia (CML). Patients who fail or are intolerant to IM therapy are treated with more expensive second and third-generation tyrosine kinase inhibitors. Patients show wide variation in trough concentrations in response to standard dosing. Thus, many patients receive subtherapeutic or supratherapeutic doses. Therapeutic drug monitoring (TDM) may improve dose management that, in turn, may reduce costs and improve outcomes. However, TDM also adds to the cost of patient care. The objective of this study was to determine the cost-effectiveness of TDM for generic IM therapy.

Source

Imatinib Drugs Market Size

Growth Forecast Report on “Imatinib Drugs Market size | Industry Segment by Applications (Hospitals, Drug Stores and Other), by Type (Capsules and Tablets), Regional Outlook, Market Demand, Latest Trends, Imatinib Drugs Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts – 2025.” Analyzes current market size and upcoming 5 years growth of this industry.

An up- to -date information inclusive with this Imatinib Drugs Market report is an exclusive information generated by industry experts for evaluating the Market and supporting deliberate decision making. The report identifies the rapidly growing and competitive environment, Imatinib Drugs Market report provides information on latest trends and expansions, and focuses on market growth in terms of revenue, sales, production and technological advancements etc.

Manufacturer / Potential Investors, Traders, Distributors, Wholesalers, Retailers, Importers and Exporters, Association and government bodies are the main audience for Imatinib Drugs market involved in this report.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/7237

Report Scope: 

Imatinib Drugs market competition by top Manufacturers: 

  • Apotex Inc.
  • Novartis
  • Sanofi S.A.
  • Cipla Inc.
  • Mylan Pharms Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Sun Pharmaceuticals
  • Actavis Generics
  • Dr. Reddy’s Laboratories
  • Teva Pharmaceutical Industries Ltd

Imatinib Drugs Market Outlook by Applications: 

  • Hospitals
  • Drug Stores
  • Other

Imatinib Drugs Market Statistics by Types: 

  • Capsules
  • Tablets

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Imatib - Imatinib
Average rating:  
 1 reviews
by Don Hong, China on Imatib - Imatinib

Hi,



Just let you know that we have received the package. Thank you for your support.